7 Best Growth Stocks for the Rest of 2026

Well, it looks like they’re going to do it. Despite a lot of turbulence in both the headlines and the markets, growth stocks are on pace to deliver yet another strong year, just like Wall Street expected.

Here’s hoping I didn’t jinx it.

A quick recap: Equities were hobbled early in 2026 by numerous concerns, including fading economic growth, new tariff policies, and another government shutdown. That was all before America’s war with Iran, which sent the major indexes near or into correction territory. Even the typically growth-happy tech sector struggled as artificial intelligence (AI) advancements raised fears that the rapidly evolving technology could displace numerous software makers and other IT industries.

However, Wall Street’s pros remained unbowed, keeping their optimistic ratings in place across the sector. And they weren’t wrong: A little froth off the top made these growth stocks look more attractive from a valuation standpoint, and investors have spent the past few months buying back in and sending the major indexes to new highs.

But what comes next?

Today, I’m going to look at the best growth stocks for the rest of 2026 and beyond. These are companies that Wall Street’s analyst community believes will rapidly grow their top and bottom lines in the years to come—and whose stocks they expect will be propelled higher as a result.

Editor’s Note: Tabular data shown in this article are up-to-date as of Oct. 6, 2026.

Featured Financial Products

Disclaimer: This article does not constitute individualized investment advice. Individual securities, funds, and/or other investments appear for your consideration and not as personalized investment recommendations. Act at your own discretion.

Growth Stock Research Tools—Our Top Picks

---

What Is a Growth Stock?

---

A growth stock is generally viewed as a company that is improving sales and profits with each passing year—typically at a faster clip than the industry average. This should, in theory, result in faster stock price appreciation as other shareholders get wise to this success and decide to buy in themselves. 

Growth stocks tend to be viewed in opposition to value stocks, which might not grow as fast but have substantial underlying operations that the market is underappreciating (for now).

So, what metrics do we want to look at?

Growth stocks tend to boast rapid sales. Income matters, too—though it’s more important among more established companies, as smaller growth stocks often burn all their cash on expansion. Expectations matter, too, because if rapid growth still falls short of Street estimates, these supposedly highflying companies might still see their stocks slump.

Similarly, we have to consider the competition. For instance, if an AI company is growing at a 40% rate, that might sound great, but if similar companies are growing at a 50%-plus clip, that AI company could be viewed as a laggard.

In other words: Not all growth stocks are good investments, even if they’re growing … heck, even if they’re growing quickly! That means we have to look past the surface to really find the best growth stocks to buy.

The Best Growth Stocks to Buy Now

---

The top growth stocks right now are companies expanding faster than the broader market, as well as their peers. That often involves riding a long-term trend that will result in a durable tailwind for years to come.

Nothing is certain on Wall Street, of course, and growth stocks that showed strong revenue trends or stock price appreciation over the past year might still stumble if things change in the months to come. That said, investors who pay attention to growth stock data can often identify companies moving into favor—and share in their success.

Today, I’ll look at some of the best growth stocks to buy right now based on recent performance, financial metrics, and equity analysts’ ratings and growth projections. I’ll include both long-term earnings-growth estimates and consensus analyst ratings, courtesy of S&P Global Market Intelligence. The consensus rating is the average of all known analyst ratings of the stock, boiled down to a numerical system where …

• 1-1.5 = Strong Buy
• 1.5-2.5 = Buy
• 2.5-3.5 = Hold
• 3.5-4.5 = Sell
• 4.5-5 = Strong Sell

In short, the lower the number, the better the overall consensus view on the stock.

All stocks here are rated at least 2.0 or below, meaning at worst they’re solidly in the Buy camp, though most of the picks are considered Strong Buys as we near the end of 2026.

Do you want to get serious about saving and planning for retirement? Sign up for Retire With Riley, our free retirement planning newsletter.

7. Neurocrine Biosciences

---

• Sector: Healthcare
• Market cap: $14.6 billion
• Long-term earnings growth estimate: 41%
• Consensus analyst rating: 1.41 (Strong Buy)

Any list of the best growth stocks is bound to include the occasional pharmaceutical or biotechnology name. And that’s the case here, with Neurocrine Biosciences (NBIX) leading off our list of Wall Street’s most favored growth investments.

Neurocrine discovers and develops treatments for neurological, neuroendocrine, and neuropsychiatric disorders. Its commercial products include Ingrezza (tardive dyskinesia and chorea associated with Huntington’s disease), Alkindi (adrenal insufficiency), Orilissa (endometriosis), and Efmody and Crenessity (classic congenital adrenal hyperplasia, or CAH).

Related: The Best Healthcare ETFs: 5 Wholesome Picks

The last drug there is a relative newbie to the lineup, earning FDA approval in late 2024. But Crenessity is fast becoming a major contributor to Neurocrine’s top line, and it helped the company beat expectations in its most recent earnings report.

“The [second-quarter] report reflected strength across multiple products with a total revenue beat of ~$67M, driven by Ingrezza and Crenessity,” Wedbush analysts Laura Chico and Thomas Yip (Outperform, equivalent of Buy) said following the company’s most recent earnings announcement. “Crenessity and a partial quarter of Vykat XR revenue combined for more than $200 million and represents meaningful diversification beyond Ingrezza.”

Related: 9 Space ETFs for the Next Frontier of Investing

“Psychiatry opportunities appear well-positioned for commercialization,” add Oppenheimer analysts, who also have NBIX at Outperform. “We asked about the potential launches for osavampator and direclidine, and management emphasized that existing infrastructure provides a strong foundation while [phase 3 trial] readouts remain on track for 2027. We see an underappreciated advantage for NBIX to leverage commercial scale, and believe osavampator could eventually benefit from [primary care physician] expansion.”

The broader analyst community is plenty rosy on Neurocrine Biosciences shares—currently, 25 pros rate shares a Buy, versus four Holds and zero Sells. They see the company growing its top line by about 30% annually through the end of 2027, and the bottom line by around 40% annually across the next three to five years.

The current consensus price target of $207 per share implies that NBIX has another 45% in upside over the next 12 months.

Related: The 10 Best Vanguard Index Funds You Can Buy

6. Micron

---

• Sector: Technology
• Market cap: $1.2 trillion
• Long-term earnings growth estimate: 192%
• Consensus analyst rating: 1.37 (Strong Buy)

Micron Technology (MU) specializes in memory and storage products, such as dynamic random-access memory (DRAM), NAND flash memory, and solid-state drives (SSDs). It serves a wide variety of markets, including PCs, graphics, networking, automotive, industrial, and consumer. Perhaps its most important right now is data centers, where AI-driven demand has helped to reinvigorate prices for NAND and DRAM broadly.

“In the age of AI, no company other than Nvidia has blown away consensus expectations as measurably as Micron has done with its quarterly results across FY26 and now with guidance into FY27,” says Argus analyst Jim Kelleher (Buy). “Growth is being driven by surging prices and AI demand for high bandwidth memory (HBM), along with soaring DRAM volumes, favorable mix, and improved NAND demand.”

UBS analysts made a stir in late May with a wild price-target upgrade on MU stock that implied Micron’s shares could more than double within the next year or so.

Related: 8 Best Stock Picking Services, Subscriptions, & Sites

“Our supply chain work on ‘Long Term Agreements (LTAs) across the memory industry’ [another UBS report] suggests that up to 30% of DDR volumes industry-wide will be soon locked in at pricing that is just slightly below current levels, and these agreements will allow MU to trade some near-term revenue for demand visibility and a smoother earnings profile,” UBS analyst Tim Arcuri (Buy) wrote in a research note.

He stressed the company’s durability at the time, and continued to do so in an October note: “Customers are now extending supply agreements into C2031 and we think these agreements will prove more durable than many investors fear because most are set in a way that would require pricing to go down well over 70% for customers to consider walking away,” Arcuri writes.

MU lost a few Buy calls in the second half of 2025 amid a run-up in shares, but the bull camp has been filling back up. Currently, Micron stock enjoys 45 Buy calls versus just three Holds and one Sells. Meanwhile, their expectations for the top and bottom lines are sky-high. Revenues are expected to pop by 140% between 2025 and 2027, while consensus estimates peg earnings growth at 190% annually over the next three to five years.

Related: 7 Best Stock Advisor Websites & Services to Seize Alpha

Need Help Picking Stocks? Consider These Top-Rated Services

---

5. Monolithic Power Systems

---

• Sector: Technology
• Market cap: $72.6 billion
• Long-term earnings growth estimate: 34%
• Consensus analyst rating: 1.35 (Strong Buy)

Semiconductor stocks will always feature prominently in any list of the best growth stocks, but Monolithic Power Systems (MPWR) isn’t your average chip company. 

MPWR designs, produces, and sells power circuits found in the automotive, enterprise data, consumer, communications, industrial, and other markets worldwide. These systems help convert and control voltages of a wide array of electronic systems, from servers, apps, and notebooks to home appliances and satellite communications. That’s a big change from where Monolithic used to be.

Related: 15 Dividend Kings for Royally Resilient Income

“MPS is one of the best-positioned semiconductor names for upside this year,” say Oppenheimer analysts, who rate the stock at Outperform. “A deep product pipeline and steady flow of design wins have steadily diversified MPWR away from traditional consumer products and into the communications, industrial, automotive, and networking markets. MPWR sets up well to outperform the broader semiconductor market with both an improving margin profile and an accelerating top-line outlook.”

Monolithic’s boffo 2026 calmed down during the summer months, but it has recovered of late and is up by more than 55% year-to-date as I write this. You can thank a couple of solid quarterly earnings reports and a 28% hike to the dividend, to $2 per share quarterly.

Related: The 7 Best REITs to Buy for the Rest of 2026

“Monolithic Power reported another strong beat-and-raise quarter as AI infrastructure demand pulls through significant power silicon content,” say William Blair’s Sebastien Naji and Ana Bilbao, who rate the stock at Buy. “An even stronger third-quarter guide calls for higher growth in the back half of 2026 as new generation GPU and ASIC programs ramp up. MPS’s continued technology leadership, strong alignment to AI spending, and diverse set of growth vectors position it well to maintain its track record of outperformance.”

MPWR isn’t as widely covered as bigger-name tech stocks, but it still enjoys a stellar consensus rating. Broken down by call, Monothlic Power Systems boasts 15 Buys versus just two Holds and no Sells.

Looking forward, analysts expect revenues to improve by around 45% annually over the next two years, and longer-term estimates peg profit growth at 34% per year on average.

Make Young and the Invested your preferred news source on Google

Simply go to your preferences page and select the ✓ box for Young and the Invested. Once you’ve made this update, you’ll see Young and the Invested show up more often in Google’s “Top Stories” feed, as well as in a dedicated “From Your Sources” section on Google’s search results page.

Featured Financial Products

4. Nvidia

---

• Sector: Technology
• Market cap: $5.8 trillion
• Long-term earnings growth estimate: 50%
• Consensus analyst rating: 1.30 (Strong Buy)

Nvidia (NVDA) isn’t just the world’s largest tech stock by market capitalization, but the largest stock period, thanks to its dominance in semiconductors that are used in cutting-edge technologies.

No. 1 with a bullet is the artificial intelligence market, and at least for now, Nvidia is king of that market. But applications for this firm’s hardware also include self-driving cars, cryptocurrency mining, and other in-demand and growth-oriented areas of the 21st century economy.

Related: 7 Best High-Yield Dividend ETFs for Income-Hungry Investors

“For every $1 spent on an NVDA chip, we estimate an $8 to $10 multiplier rippling across the ecosystem,” says a team of Wedbush analysts led by Dan Ives (Outperform). “Hyperscalers, software, data center buildouts, cybersecurity, and power/energy are set to benefit from the $3 to $4 trillion of AI capex set to take place over the next three years as Nvidia’s chips remain at the epicenter of this 4th Industrial Revolution.”

Nvidia has unsurprisingly been a font of growth, and that’s not expected to end anytime soon. Analysts see revenues basically doubling in each of the next two years, and they expect earnings to grow by 50% annually over the long term—an almost shocking clip for a nearly $6 trillion company. 

And NVDA recently gave investors one more reason to love the stock:

Related: 11 Best Vanguard Funds for the Everyday Investor

“This was the quarter you’ve been waiting for,” Truist Managing Director William Stein wrote after the company’s recently announced fiscal Q2 report. “In several recent quarters, NVDA delivered a beat-and-raise, and investors shrugged it off,” he said. “This quarter, NVDA also noted that demand supports 100% sales growth next year, but that supply constraints will limit growth to 70% (consensus was +47%). We expect this strong statement will allow NVDA to extend its after-hours rise, and that the broader AI trade (suppliers with high AI concentration) will begin to recover.”

Nvidia boasts the largest bull camp, by total analysts, in our list of 2026’s best growth stocks: a whopping 58 Buys. That compares to just two Holds and a lonely Sell. As a group, they see Nvidia stock hitting $328.72 within the next year, which would represent a 37% improvement from current levels.

Make sure you sign up for The Weekend Tea, our free weekly newsletter that over 10k monthly readers use to level up their money know-how.

3. Smurfit Westrock

---

• Sector: Consumer discretionary
• Market cap: $22.3 billion
• Long-term earnings growth estimate: 34%
• Consensus analyst rating: 1.29 (Strong Buy)

Smurfit Westrock (SW)—the product of a 2024 merger of Ireland’s Smurfit Kappa and America’s Westrock—is a global manufacturer of consumer packaging, corrugated packaging, and a variety of paper products. And by virtue of that merger, the combined entity is now one of the largest packaging providers in the world, with operations in 40 countries.

Related: 7 Best Fidelity Dividend Funds [Passive Income Picks]

Consider Smurfit Westrock an interesting beneficiary of technological trends—specifically, the continued rise of e-commerce. As people increasingly move away from buying in brick-and-mortar stores and toward online shopping … well, those products have to get shipped in something, and that’s precisely where Smurfit comes in.

“[We estimate] that the industry will remain strong, and we see modest expansion at a compound annual growth rate of 3%-4% through 2028,” writes Argus Research analyst Alexandra Yates, who rates SW shares at Buy. “We favor companies with pulp, paperboard packaging, and corrugated product lines, and expect this segment to show continued long-term growth through 2030.

“We see long-term upside potential and expect earnings growth congruent with growth in e-commerce and growth in demand for sustainable paper and packaging goods. We think that current valuation multiples are attractive given the company’s recovering earnings outlook through FY26.”

Related: Motley Fool Stock Advisor Review: Steady Eddies

Among the other bulls is Truist Managing Director Michael Roxland, who likes SW “given its leading industry position in North America containerboard, allowing it to capitalize on the improving containerboard cycle, which we believe is entering a ‘golden age’ driven by balanced supply & demand, and new and disciplined managements focused on return generation.”

SW has picked up quite a few covering analysts of late, and they’re unanimously bullish, with all 16 calling the stock a Buy. Their consensus $56.72 price target implies Smurfit’s stock could climb another 34% over the next year or so. Top-line growth expectations are modest, sitting in single digits, but analysts think Smurfit can expand its bottom line by 34% annually over the long run.

By the way: Smurfit isn’t just growing its top and bottom lines—it’s also raising the bar on its dividend. The company boasts 14 consecutive years of uninterrupted increases to the cash distribution (including pre-merger data), earning a space among our top dividend-growth stocks, too.

Related: 5 Dandy Dividend-Growth ETFs to Buy Now

2. Comfort Systems USA

---

• Sector: Industrials
• Market cap: $64.3 billion
• Long-term earnings growth estimate: 45%
• Consensus analyst rating: 1.20 (Strong Buy)

Comfort Systems USA (FIX) provides mechanical, electrical, and plumbing (MEP) contracting services. It offers heating, ventilation, and air conditioning (HVAC) systems, plumbing, electrical, modular construction, even fire protection. It installs, maintains, repairs, and replaces these systems in both new and existing buildings.

Related: 8 Best Vanguard Retirement Funds for a 401(k)

It’s a cyclical business, but one that has been given a shot in the arm by a demand boom in data centers and other advanced manufacturing projects. Revenues quadrupled between 2020 and 2025. Net income has exploded by 580% in that time. And shares have reflected that wild growth, rocketing roughly 2,250% higher over the past five years.

Wall Street thinks the good times can keep rolling, too.

Related: The 10 Best ETFs for Beginners

“Comfort Systems is uniquely positioned to leverage capacity investments in data centers, manufacturing and other critical sectors, with significant customer planning occurring in core Comfort markets served,” say Oppenheimer analysts, who rate the stock at Outperform. “Modular supplements opportunities in these core regions. These factors have supported (and likely will continue to support) superior growth and margin expansion potential vs. most industry peers over the near and medium term. We expect these factors, coupled with substantial excess liquidity in support of strategic initiatives, to lend varying upside levers to support a valuation premium to the industry peer group.”

FIX doesn’t have a huge analyst following, but nine of the 10 that cover the stock call it a Buy, with the lone dissenter a Hold. Meanwhile, an average price target of $2,197 implies an additional 28% of upside over the next year or so.

Also worth noting is that Comfort Systems’ breakneck growth is also reflected in the company’s dividend. The company offers a meager 0.2% headline yield, but that’s largely an effect of its constantly rising share price. But the distribution has expanded from 10.5¢ per share quarterly in 2020 to 90¢ today, for a whopping expansion of 757%. That puts FIX in elite company of being both one of the market’s top dividend-growth stocks and one of the best growth stocks period.

Related: 13 Best Stock Screeners + Stock Scanners [Apps & Sites]

1. Somnigroup International

---

• Sector: Consumer discretionary
• Market cap: $14.5 billion
• Long-term earnings growth estimate: 20%
• Consensus analyst rating: 1.20 (Strong Buy)

Somnigroup International (SGI) is one of the largest bedding companies in the world, designing, manufacturing, distributing, and retailing bedding products in the U.S. and internationally. It operates a portfolio of brands including Mattress Firm, Dreams, Tempur-Pedic, and SOVA, and it licenses other brands such as Sealy, Tempur, and Stearns & Foster.

SGI was created by a merger of Tempur Sealy International and Mattress Firm Group, which closed in February 2025. The stock enjoyed a healthy climb through the rest of 2025, but it has fallen back to earth this year, off 30% thanks in large part to oil-price spikes that have raised input costs, pushed the Federal Reserve into at least one interest-rate hike, and weakened consumer demand. 

Related: 10 Best Schwab ETFs to Buy [Build Your Core for Cheap]

Still, analysts believe SGI could be one of 2026’s top rebound stocks, in large part because of the recent Chapter 11 filing of rival Sleep Number.

“This could mean a sizeable market share opportunity up for grabs,” UBS analyst Dan Silverstein says. “Recall, the company ended 1Q’26 with 577 stores and TTM sales of $1.4 billion. We think SGI could capture market share; there’s significant market share opportunity. There’s a high degree of competitive overlap. Within a 5-mile radius, ~95% of SNBR locations have a Mattress Firm store nearby; ~16% have a Tempur-Pedic store nearby. Over ~96% of SNBR locations have at least one Mattress Firm store within a 15-mile radius.”

Truist Managing Director Keith Hughes (Buy) adds that “almost all domestic mattress purchases now include revenue to SGI.”

The pros think Somnigroup will grow the top line by 25% annually through the end of 2027, and improve the bottom line by 20% annually over the longer term. And while SGI’s coverage camp isn’t big, all 10 analysts following it call the stock a buy, with a price target implying 50% upside—good enough to put this recovery play among Wall Street’s very best growth stocks to buy.

Featured Financial Products

Related: The 7 Best Gold ETFs You Can Buy

Should I Buy Growth Stocks or a Growth Exchange-Traded Fund?

---

Growth-oriented investing strategies are always in-demand, so there are a host of exchange-traded funds (ETFs) out there that own growth stocks. The largest, the Vanguard Growth ETF (VUG), commands more than $230 billion in assets as proof of the popularity of this approach.

ETFs allow for easy diversification as you invest tactically in growth stocks. But keep in mind that by spreading your money around and reducing your risk, you also limit your upside. Many growth investors are enamored with the idea of a stock that doubles in short order—and that’s almost impossible with an ETF that holds hundreds of different components.

In short: Whether you buy growth stocks or an ETF depends on your personal risk tolerance.

Related: 7 Best Closed-End Funds (CEFs) Paying Us Up to 17.2%

Related: The 10 Best Dividend ETFs You Can Buy

We love exchange-traded funds (ETFs) because they can provide one-click access to hundreds, even thousands of stocks, while charging often minuscule fees.

One way to put that low-cost diversification to work? Collecting dividends. But trying to choose from literally hundreds of income-producing funds could take up a lot more time than you have. So let us help you narrow the field—check out our list of 10 top dividend ETFs.

Related: 7 Best Vanguard Dividend Funds for 2026

What’s better than a smart, sound dividend income strategy? How about a smart, sound dividend income strategy with very little money coming out of your pocket?

If that sounds good to you, you need look no farther than low-cost pioneer Vanguard, which offers up a number of payout-oriented products. Find out what you need to know in our list of seven top-notch Vanguard dividend funds.

Please Heart ❤️, Follow and Subscribe 

Did you find this article helpful? 

1. Click the Heart Button. 

2. Follow WealthUpdate —-> https://flipboard.com/@WealthUpdate

3. Subscribe to Retire With Riley, our free weekly retirement planning newsletter.

Read More

---

• Plynk Review: Great for All Investors, Easy on Beginners
• Empower Personal Strategy Review: Wealth Management More People Can Afford
• Morningstar Investor Review: Is This Research Tool Right for You?